0001209191-15-043845.txt : 20150518
0001209191-15-043845.hdr.sgml : 20150518
20150518170041
ACCESSION NUMBER: 0001209191-15-043845
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20150514
FILED AS OF DATE: 20150518
DATE AS OF CHANGE: 20150518
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TETRAPHASE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001373707
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 ARSENAL STREET
STREET 2: SUITE 110
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617.715.3600
MAIL ADDRESS:
STREET 1: 480 ARSENAL STREET
STREET 2: SUITE 110
CITY: WATERTOWN
STATE: MA
ZIP: 02472
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lubner David Charles
CENTRAL INDEX KEY: 0001572000
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35837
FILM NUMBER: 15873924
MAIL ADDRESS:
STREET 1: C/O TETRAPHASE PHARMACEUTICALS, INC.
STREET 2: 480 ARSENAL STREET, SUITE 110
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-05-14
0
0001373707
TETRAPHASE PHARMACEUTICALS INC
TTPH
0001572000
Lubner David Charles
480 ARSENAL ST. SUITE 110
WATERTOWN
MA
02472
0
1
0
0
SVP and CFO
Common Stock
2015-05-14
4
M
0
7684
2.03
A
86954
D
Common Stock
2015-05-14
4
S
0
7684
39.28
D
79270
D
Common Stock
2015-05-14
4
M
0
7316
2.03
A
86586
D
Common Stock
2015-05-14
4
S
0
7316
39.28
D
79270
D
Employee Stock Option (right to buy)
2.03
2015-05-14
4
M
0
7684
0.00
D
2020-09-27
Common Stock
7684
0
D
Employee Stock Option (right to buy)
2.03
2015-05-14
4
M
0
7316
0.00
D
2022-06-05
Common Stock
7316
27043
D
The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2015.
The amount of securities beneficially owned by the reporting person following the transaction reported on this Form 4 reflects the purchase by the reporting person of 402 shares of common stock on November 17, 2014 and 405 shares of common stock on May 14, 2015. Both of these purchases were done under the issuer's 2014 Employee Stock Purchase Plan ("ESPP"). The shares purchased in November 2014 under the ESPP were inadvertently omitted from the amount of securities beneficially owned that were reported on the Form 4 filed by the reporting person on January 9, 2015.
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $38.03 to $39.89 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This option is fully vested.
This option vests as to 6.25% of the shares on September 6, 2012 and further vests as to 6.25% of the shares at the end of each of successive three-month period thereafter until June 6, 2016.
/s/Maria Stahl as Attorney-in-Fact for David Lubner
2015-05-18
EX-24.4_583224
2
poa.txt
POA DOCUMENT
LIMITED POWER OF ATTORNEY
FOR SECTION 16 REPORTING OBLIGATIONS
Know all by these presents, that the undersigned hereby makes, constitutes and
appoints each of David Lubner and Maria Stahl, signing singly and each acting
individually, as the undersigned's true and lawful attorney in fact with full
power and authority as hereinafter described to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer and/or director of Tetraphase Pharmaceuticals, Inc. (the
"Company"), Forms 3, 4, and 5 (including any amendments thereto) in accordance
with Section 16(a) of the Securities Exchange Act of 1934 and the rules
thereunder (the "Exchange Act");
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to prepare, complete and execute any such Form 3,
4, or 5, prepare, complete and execute any amendment or amendments thereto, and
timely deliver and file such form with the United States Securities and Exchange
Commission and any stock exchange or similar authority;
(3) seek or obtain, as the undersigned's representative and on the undersigned's
behalf, information regarding transactions in the Company's securities from any
third party, including brokers, employee benefit plan administrators and
trustees, and the undersigned hereby authorizes any such person to release any
such information to such attorney in fact and approves and ratifies any such
release of information; and
(4) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney in fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney in fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney in fact may approve in such
attorney in fact's discretion.
The undersigned hereby grants to each such attorney in fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney in fact, or such attorney
in fact's substitute or substitutes, shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and powers herein granted. The
undersigned acknowledges that the foregoing attorneys in fact, in serving in
such capacity at the request of the undersigned, are not assuming nor relieving,
nor is the Company assuming nor relieving, any of the undersigned's
responsibilities to comply with Section 16 of the Exchange Act. The undersigned
acknowledges that neither the Company nor the foregoing attorneys in fact assume
(i) any liability for the undersigned's responsibility to comply with the
requirement of the Exchange Act, (ii) any liability of the undersigned for any
failure to comply with such requirements, or (iii) any obligation or liability
of the undersigned for profit disgorgement under Section 16(b) of the Exchange
Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys in fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 12th day of March, 2015.
/s/David Lubner
Signature
David Lubner